The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Dexafort Suspension for Injection

1.32/2.67 milligram(s)/millilitre Suspension for injection

Intervet Ireland LimitedVPA10996/028/001

Main Information

Trade NameDexafort Suspension for Injection
Active SubstancesDexamethasone sodium phosphate
Dexamethasone phenylpropionate
Strength1.32/2.67 milligram(s)/millilitre
Dosage FormSuspension for injection
Licence HolderIntervet Ireland Limited
Licence NumberVPA10996/028/001

Group Information

ATC CodeQH02AB02 dexamethasone
Therapeutic ClassCorticosteroid


Licence Issued01/10/1989
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back